New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells.
Ciocan-Cartita CA, Jurj A, Zanoaga O, Cojocneanu R, Pop LA, Moldovan A, Moldovan C, Zimta AA, Raduly L, Pop-Bica C, Buse M, Budisan L, Virag P, Irimie A, Gomes Dias SM, Berindan-Neagoe I, Braicu C.
Ciocan-Cartita CA, et al. Among authors: raduly l.
J Exp Clin Cancer Res. 2020 Nov 13;39(1):241. doi: 10.1186/s13046-020-01736-2.
J Exp Clin Cancer Res. 2020.
PMID: 33187552
Free PMC article.